Structure Therapeutics (NASDAQ:GPCR) Stock Quotes, Forecast and News Summary

Q: What sector and industry does Structure Therapeutics (GPCR) operate in?

Structure Therapeutics is in the Health Care sector and Pharmaceuticals industry. They are listed on the NASDAQ.

Structure Therapeutics Stock (NASDAQ: GPCR) stock price, news, charts, stock research, profile.

Open	$38.32
Close	$37.23
Volume / Avg.	965.82K / 1.01M
Day Range	36.75 - 39.18
52 Wk Range	25.57 - 75.02
Market Cap	$2.12B
P/E Ratio	-
Dividend Yield	-
Exchange	NASDAQ
RSI	37
Short Interest	14.67%
Days to Cover	2.32

Recent News

Structure Therapeutics Obesity Candidate Is 'Very Competitive' To Eli Lilly's Orforglipron, Analyst Says

Structure Therapeutics reports positive 12-week Phase 2a obesity study results for GSBR-1290, showing a 6.2% weight loss. Cantor Fitzgerald maintains an Overweight rating with a $65 target

Vandana Singh

Why Science Applications International Shares Are Trading Lower By 11%? Here Are Other Stocks Moving In Monday's Mid-Day Session

Avi Kapoor

Obesity Data From Structure Therapeutics Shows Potential For Weight Loss Drug Candidate

Structure Therapeutics announces Phase 2a results for GSBR-1290, showing significant weight loss in obesity study.

Vandana Singh

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Analyst Trends and Forecast

Mar

Apr

May

Jun

Jul

Buy

Hold

Sell

Strong Sell

Analyst Rating and Forecast

4.5

Buy

Strong Buy

Buy

Hold

Sell

Strong Sell

About Structure Therapeutics Inc

Sector

Health Care

Industry

Pharmaceuticals

Structure Therapeutics Inc is a clinical-stage biopharmaceutical company aiming to develop and deliv...

Compare

EPS worse than industry

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

EPS worse than industry

FAQ

How do I buy Structure Therapeutics (GPCR) stock?

You can purchase shares of Structure Therapeutics (NASDAQ:GPCR) through any online brokerage.

View our list of the best stock brokerages

Who are Structure Therapeutics (GPCR) competitors?

Other companies in Structure Therapeutics’s space includes: Verona Pharma (NASDAQ:VRNA), Supernus Pharmaceuticals (NASDAQ:SUPN), Neumora Therapeutics (NASDAQ:NMRA), Longboard Pharmaceuticals (NASDAQ:LBPH) and Axsome Therapeutics (NASDAQ:AXSM).

What is the target price for Structure Therapeutics (GPCR) stock?

There is no analysis for Structure Therapeutics.

What is the forecast for Structure Therapeutics (GPCR) stock?

Structure Therapeutics has a consensus price target of $72.88.

Current stock price for Structure Therapeutics (GPCR)?

The stock price for Structure Therapeutics (NASDAQ: GPCR) is $37.23 last updated Today at July 8, 2024 at 4:00 PM EDT.

Does Structure Therapeutics (GPCR) pay a dividend?

There are no upcoming dividends for Structure Therapeutics.

When is Structure Therapeutics (NASDAQ:GPCR) reporting earnings?

Structure Therapeutics’s Q2 earnings are confirmed for Wednesday, August 14, 2024.

Is Structure Therapeutics (GPCR) going to split?

There is no upcoming split for Structure Therapeutics.

What sector and industry does Structure Therapeutics (GPCR) operate in?

Structure Therapeutics is in the Health Care sector and Pharmaceuticals industry. They are listed on the NASDAQ.

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Structure Therapeutics

Structure Therapeutics (GPCR) Forecast